BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Market Share for Induced Pluripotent Stem Cell (iPSC) Research Products, by Product Category
Market research for iPSC research products

Market Share for Induced Pluripotent Stem Cell (iPSC) Research Products, by Product Category

June 25, 2015 By Cade Hildreth (CEO) Leave a Comment

Since their discovery in 2006, induced pluripotent stem cells (iPSCs) have been commercialized in a number of different ways. iPSCs have been used as tools for drug development and discovery, for toxicology applications, in stem cell biobanking, in personalized medicine, and as research products.  While each of these commercial applications is important, this post specifically considers the use of iPSCs as research products – meaning, tools that scientists use in their labs for research purposes and applications.

Discover class-defining bioproduction tools.

Specifically, this post explores the breakdown of induced pluripotent stem cells (iPSCs) research products, by category. This analysis is intended to direct the decision-making of research supply companies by indicating where there is high market demand at this time.  (To learn about future directions for iPSCs, click here.)

Induced Pluripotent Stem Cell (iPSC) Research Product Categories

The following is a breakdown of research product categories in which iPSC products can be developed.  It is valuable to consider these categories during new product development, because it can assist with diversifying and expanding a company’s existing stem cell product portfolio.  Therefore, functionally-defined iPSC product categories are shown below, accompanied by a brief description of each.

Functionally-Defined Induced Pluripotent Stem Cell (iPSC) Product Categories

Category
Brief Description
Reprogramming iPSC reprogramming spans from traditional reprogramming methods (lentivirus) to non-integrating technologies (Sendai virus and episomal vectors), and more.
Cell Culture iPSC research requires careful attention to culture conditions, including optimal solutions for iPSC environments. Optimized iPSC-specific cell culture products (serum, media, passaging reagents, substrates, etc.) deliver confidence and predictable outcomes to iPSC researchers.
Engineering Engineering iPSCs involves analyzing gene and protein expression, as well as studying differentiation and disease pathways. Options include lipid/electroporation-based transfection products and a wide range of cloning technologies.
Differentiation Targeted differentiation of iPSCs requires high-quality growth factors and cytokines, tested for high biological activity, high purity, freeze-thaw stability, and structural homogeneity. iPSC optimized tools for differentiation (including cell culture media and reagents, as well as custom media services), allow for the optimal growth, expansion, and storage of differentiated iPSCs.
Cell Analysis Validating iPSCs to ensure they are pluripotent or have differentiated into the desired cell lineage is a critical step in this stage of research. Tools in this product category assist with quickly confirming that cells are pluripotent/differentiated and provide for flexibility in antibody and dye choice.

Induced Pluripotent Stem Cell (iSPC) Market Share, by Product Category

When respondents to BioInformant’s “2014 Survey of Induced Pluripotent Stem Cell Researchers” were asked to report the primary product category from which they purchase iPSC products, the following results were reported (131 U.S. Respondents / 143 International Respondents).

Rooster DevServices

iPSC Market Share Breakdown, by Product Category

Functional iPSC Product Category
% of Respondents
Reprogramming 34.1%
Cell Culture 23.1%
Differentiation 13.1%
Cell Analysis 9.2%
Engineering 7.8%
Other/Undefined 12.7%
TOTAL 100%

iPSC market share breakdown by functional product category

bitbio

To view full findings from BioInformant’s end-user survey of iPSC researchers, view the “Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report.”

Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry ReportTo receive future posts about the stem cell industry, sign-up here. We will never share your information with anyone, and you can opt-out at any time. No spam ever, just great stuff.

Pluristyx


About Us

BioInformant is the only research firm that has served the stem cell sector since it emerged. Our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and applies these techniques to the field of market research. BioInformant has been featured on news outlets including the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking.

iPSC-derived cardiomyocte therapy

BioInformant_Logo_header_white

Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, Beckton Dickinson, and Thermo Fisher Scientific, BioInformant is your global leader in stem cell industry data.

Rate this post

Filed Under: iPS Cells, Stem Cells Tagged With: induced pluripotent stem cells, iPSC, iPSC market share, iPSC research products, market research, market share

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Featured Posts

what are exosomes | definition

What are Exosomes, Exactly?

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

iPSC derived cell therapeutics

The Pipeline for iPSC-Derived Cell Therapeutics in 2022

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.